4 ms·

Can you provide a citation for the EMA doing parallel processing because I have yet to hear about that and in fact read the opposite. It's not in AZ's interest

Can you provide a citation for the EMA doing parallel processing because I have yet to hear about that and in fact read the opposite. It's not in AZ's interest to keep an expensive factory idled in an environment of unprecedented demand, obviously. They want to sell vaccine to whoever will take it. AZ is "unwilling" to deliver to the EU because it has signed contracts putting other countries first and they are able to consume the entire supply. Once the UK is done, they will suddenly become "willing" (if such a term makes sense when contracts are involved) to deliver to the EU as well. So to be clear, you are describing factual statements as speculation (which is wrong) and then making spurious claims about AZ/EMA's claimed interests instead of what they're actually doing.

tuukkah 6y ago
> Can you provide a citation for the EMA doing parallel processing "Rolling review" is the term I've seen typically used for the process that you described, and Wikipedia has references for various rolling reviews by EMA starting with the following: "In October 2020, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) started 'rolling reviews' of the vaccines known as COVID-19 Vaccine AstraZeneca (ChAdOx1-SARS-CoV-2) and Pfizer-BioNTech COVID-19 Vaccine (BNT162b2)." https://en.wikipedia.org/wiki/History_of_COVID-19_vaccine_development#European_Union https://en.wikipedia.org/wiki/History_of_COVID-19_vaccine_de...
- thu2111 6y ago
  Then I wonder how it has ended in a situation where a factory is apparently ready to go to produce but is waiting for regulatory approval, and the regulators are claiming they're waiting for paperwork to be submitted. That shouldn't be possible in a genuinely parallel review process.